PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Melanoma|Breast Neoplasms|Carcinoma, Renal Cell|Lymphoma, T-Cell|Carcinoma, Non-Small-Cell Lung
Interventions: DRUG: PF-3512676
Sponsor: Pfizer